Cargando…

Ablation of high‐mobility group box‐1 in the liver reduces hepatocellular carcinoma but causes hyperbilirubinemia in Hippo signaling‐deficient mice

Silencing the Hippo kinases mammalian sterile 20‐like 1 and 2 (MST1/2) activates the transcriptional coactivator yes‐associated protein (YAP) in human hepatocellular carcinoma (HCC). Hepatocyte‐derived high‐mobility group box‐1 (HMGB1) regulates YAP expression; however, its contribution to HCC in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Athavale, Dipti, Song, Zhuolun, Desert, Romain, Han, Hui, Das, Sukanta, Ge, Xiaodong, Komakula, Sai Santosh Babu, Chen, Wei, Gao, Shenglan, Lantvit, Daniel, Guzman, Grace, Nieto, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315122/
https://www.ncbi.nlm.nih.gov/pubmed/35344292
http://dx.doi.org/10.1002/hep4.1943
_version_ 1784754483395297280
author Athavale, Dipti
Song, Zhuolun
Desert, Romain
Han, Hui
Das, Sukanta
Ge, Xiaodong
Komakula, Sai Santosh Babu
Chen, Wei
Gao, Shenglan
Lantvit, Daniel
Guzman, Grace
Nieto, Natalia
author_facet Athavale, Dipti
Song, Zhuolun
Desert, Romain
Han, Hui
Das, Sukanta
Ge, Xiaodong
Komakula, Sai Santosh Babu
Chen, Wei
Gao, Shenglan
Lantvit, Daniel
Guzman, Grace
Nieto, Natalia
author_sort Athavale, Dipti
collection PubMed
description Silencing the Hippo kinases mammalian sterile 20‐like 1 and 2 (MST1/2) activates the transcriptional coactivator yes‐associated protein (YAP) in human hepatocellular carcinoma (HCC). Hepatocyte‐derived high‐mobility group box‐1 (HMGB1) regulates YAP expression; however, its contribution to HCC in the context of deregulated Hippo signaling is unknown. Here, we hypothesized that HMGB1 is required for hepatocarcinogenesis by activating YAP in Hippo signaling‐deficient (Mst1/2 (ΔHep)) mice. Mst1/2 (ΔHep) mice developed HCC within 3.5 months of age and had increased hepatic expression of HMGB1 and elevated YAP activity compared to controls. To understand the contribution of HMGB1, we generated Mst1/2&Hmgb1 (ΔHep) mice. They exhibited decreased YAP activity, cell proliferation, inflammation, fibrosis, atypical ductal cell expansion, and HCC burden at 3.5 months compared to Mst1/2 (∆Hep) mice. However, Mst1/2&Hmgb1 (ΔHep) mice were smaller, developed hyperbilirubinemia, had more liver injury with intrahepatic biliary defects, and had reduced hemoglobin compared to Mst1/2 (ΔHep) mice. Conclusion: Hepatic HMGB1 promotes hepatocarcinogenesis by regulation of YAP activity; nevertheless, it maintains intrahepatic bile duct physiology under Hippo signaling deficiency.
format Online
Article
Text
id pubmed-9315122
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93151222022-07-27 Ablation of high‐mobility group box‐1 in the liver reduces hepatocellular carcinoma but causes hyperbilirubinemia in Hippo signaling‐deficient mice Athavale, Dipti Song, Zhuolun Desert, Romain Han, Hui Das, Sukanta Ge, Xiaodong Komakula, Sai Santosh Babu Chen, Wei Gao, Shenglan Lantvit, Daniel Guzman, Grace Nieto, Natalia Hepatol Commun Original Articles Silencing the Hippo kinases mammalian sterile 20‐like 1 and 2 (MST1/2) activates the transcriptional coactivator yes‐associated protein (YAP) in human hepatocellular carcinoma (HCC). Hepatocyte‐derived high‐mobility group box‐1 (HMGB1) regulates YAP expression; however, its contribution to HCC in the context of deregulated Hippo signaling is unknown. Here, we hypothesized that HMGB1 is required for hepatocarcinogenesis by activating YAP in Hippo signaling‐deficient (Mst1/2 (ΔHep)) mice. Mst1/2 (ΔHep) mice developed HCC within 3.5 months of age and had increased hepatic expression of HMGB1 and elevated YAP activity compared to controls. To understand the contribution of HMGB1, we generated Mst1/2&Hmgb1 (ΔHep) mice. They exhibited decreased YAP activity, cell proliferation, inflammation, fibrosis, atypical ductal cell expansion, and HCC burden at 3.5 months compared to Mst1/2 (∆Hep) mice. However, Mst1/2&Hmgb1 (ΔHep) mice were smaller, developed hyperbilirubinemia, had more liver injury with intrahepatic biliary defects, and had reduced hemoglobin compared to Mst1/2 (ΔHep) mice. Conclusion: Hepatic HMGB1 promotes hepatocarcinogenesis by regulation of YAP activity; nevertheless, it maintains intrahepatic bile duct physiology under Hippo signaling deficiency. John Wiley and Sons Inc. 2022-03-28 /pmc/articles/PMC9315122/ /pubmed/35344292 http://dx.doi.org/10.1002/hep4.1943 Text en © 2022 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Athavale, Dipti
Song, Zhuolun
Desert, Romain
Han, Hui
Das, Sukanta
Ge, Xiaodong
Komakula, Sai Santosh Babu
Chen, Wei
Gao, Shenglan
Lantvit, Daniel
Guzman, Grace
Nieto, Natalia
Ablation of high‐mobility group box‐1 in the liver reduces hepatocellular carcinoma but causes hyperbilirubinemia in Hippo signaling‐deficient mice
title Ablation of high‐mobility group box‐1 in the liver reduces hepatocellular carcinoma but causes hyperbilirubinemia in Hippo signaling‐deficient mice
title_full Ablation of high‐mobility group box‐1 in the liver reduces hepatocellular carcinoma but causes hyperbilirubinemia in Hippo signaling‐deficient mice
title_fullStr Ablation of high‐mobility group box‐1 in the liver reduces hepatocellular carcinoma but causes hyperbilirubinemia in Hippo signaling‐deficient mice
title_full_unstemmed Ablation of high‐mobility group box‐1 in the liver reduces hepatocellular carcinoma but causes hyperbilirubinemia in Hippo signaling‐deficient mice
title_short Ablation of high‐mobility group box‐1 in the liver reduces hepatocellular carcinoma but causes hyperbilirubinemia in Hippo signaling‐deficient mice
title_sort ablation of high‐mobility group box‐1 in the liver reduces hepatocellular carcinoma but causes hyperbilirubinemia in hippo signaling‐deficient mice
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315122/
https://www.ncbi.nlm.nih.gov/pubmed/35344292
http://dx.doi.org/10.1002/hep4.1943
work_keys_str_mv AT athavaledipti ablationofhighmobilitygroupbox1intheliverreduceshepatocellularcarcinomabutcauseshyperbilirubinemiainhipposignalingdeficientmice
AT songzhuolun ablationofhighmobilitygroupbox1intheliverreduceshepatocellularcarcinomabutcauseshyperbilirubinemiainhipposignalingdeficientmice
AT desertromain ablationofhighmobilitygroupbox1intheliverreduceshepatocellularcarcinomabutcauseshyperbilirubinemiainhipposignalingdeficientmice
AT hanhui ablationofhighmobilitygroupbox1intheliverreduceshepatocellularcarcinomabutcauseshyperbilirubinemiainhipposignalingdeficientmice
AT dassukanta ablationofhighmobilitygroupbox1intheliverreduceshepatocellularcarcinomabutcauseshyperbilirubinemiainhipposignalingdeficientmice
AT gexiaodong ablationofhighmobilitygroupbox1intheliverreduceshepatocellularcarcinomabutcauseshyperbilirubinemiainhipposignalingdeficientmice
AT komakulasaisantoshbabu ablationofhighmobilitygroupbox1intheliverreduceshepatocellularcarcinomabutcauseshyperbilirubinemiainhipposignalingdeficientmice
AT chenwei ablationofhighmobilitygroupbox1intheliverreduceshepatocellularcarcinomabutcauseshyperbilirubinemiainhipposignalingdeficientmice
AT gaoshenglan ablationofhighmobilitygroupbox1intheliverreduceshepatocellularcarcinomabutcauseshyperbilirubinemiainhipposignalingdeficientmice
AT lantvitdaniel ablationofhighmobilitygroupbox1intheliverreduceshepatocellularcarcinomabutcauseshyperbilirubinemiainhipposignalingdeficientmice
AT guzmangrace ablationofhighmobilitygroupbox1intheliverreduceshepatocellularcarcinomabutcauseshyperbilirubinemiainhipposignalingdeficientmice
AT nietonatalia ablationofhighmobilitygroupbox1intheliverreduceshepatocellularcarcinomabutcauseshyperbilirubinemiainhipposignalingdeficientmice